Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to evaluate immunogenicity and safety of S.flexneriza-S.sonnei Bivalent Conjugate Vaccine in healthy volunteers aged from 3 months to 5 years old.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT04865497
Study type Interventional
Source Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
Status Completed
Phase Phase 2
Start date January 19, 2019
Completion date December 31, 2020

See also
  Status Clinical Trial Phase
Completed NCT02280044 - Efficacy of Rifaximin in Preventing Campylobacteriosis Phase 2/Phase 3
Completed NCT01080716 - Safety and Efficacy Study of WRSS1, a Shigella Sonnei Vaccine Candidate Phase 1/Phase 2
Completed NCT00490932 - New Hypo-Osmolar ORS (Recommended by WHO) for Routine Use in the Diarrhea Management– Surveillance Study for Adverse Effects Phase 4
Completed NCT01306383 - Solar Disinfection (SODIS) of Drinking Water for Use in Developing Countries or in Emergency Situations N/A
Not yet recruiting NCT01638039 - Identification of Correlates of Protection Against Shigella and Enterotoxigenic Escherichia Coli Infections N/A
Completed NCT03561181 - Safety Study of S.Flexneriza-S.Sonnei Bivalent Conjugate Vaccine in Healthy Volunteers Aged Above 3 Months Phase 1
Completed NCT01672580 - Social Network Interventions in Rural Honduras N/A